Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
Compound mixture for curing cervical vertigo
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound agent and compound technology, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of high recurrence rate, slow treatment, unsatisfactory curative effect, etc., and achieve low cost, good compliance, and no side effects Effect
Inactive Publication Date: 2013-11-06
徐东强
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The disease tends to be younger, and its treatment is slow, and the recurrence rate is high. In severe cases, it can lead to cerebrovascular disease. At present, there is no complete cure. Western medicine is mainly symptomatic treatment and rehabilitation treatment, mainly to improve symptoms and curative effect. Unsatisfactory and unable to stop disease progression
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0010] Embodiment: The compound anti-glare neck compound agent of this embodiment uses Dipsacus, keel, Ligustrum lucidum, mother-of-pearl, Tribulus terrestris, Chuanxiong, Pueraria lobata, Salvia miltiorrhiza, papaya, Anemarrhena anemarrhena, Moutan bark, Shichangpu, turmeric, and licorice as Prepared from raw materials, its components (weight%) are Dipsacus 18%, keel 18%, Ligustrum lucidum 10%, mother of pearl 9%, Tribulus terrestris 8%, Chuanxiong 3%, Pueraria 6%, Salvia 6%, Papaya 4%, Anemarrhena 5%, Moutan bark 3%, Shichangpu 3%, Curcuma 3%, Licorice 4%, take the above 14 kinds of raw materials with a total weight of 56 kg, select and wash them with 20000ml of water under greenhouse conditions Soak for about 30 minutes, then decoct for 60 minutes, conventional deslag filtration, high pressure, sterilization process, the resulting filtrate is 9000ml in total, divided into bags, sealed, 150ml per bag.
[0011] 1. Case selection: 65 patients were randomly selected clinically,...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a compound mixture for curing cervical vertigo, which is characterized in that the compound mixture is prepared by the following raw materials in percent by weight through a method which comprises the following steps of: cleaning 14-22 percent of teasel root, 12-18 percent of fossil bone, 8-10 percent of Fructus ligustri Lucidi, 6-10 percent of mother of pearl, 8-10 percent of Tribulus terrestris L., 3-4 percent of Ligusticum wallichii, 6-8 percent of lobed kudzuvine root, 6-10 percent of Salvia miltiorrhiza, 5-7 percent of Chinese flowering quince, 3-6 percent of Rhizoma anemarrhenae, 4-6 percent of moutan bark, 3-5 percent of Rhizoma acori Talarinowii, 3-6 percent of Radix curcumae and 3-6 percent of licorice root, soaking the raw materials in water, boiling, removing residues to obtain filtrate, sterilizing and refining to obtain the mixture. The compound mixture for curing cervical vertigo has the efficacies of nourishing liver and kidney, calming liver wind, removing heat to cool blood, promoting blood circulation to remove meridian obstruction, activating spleen qi, resolving dampness, activating yang and promoting resuscitation, can effectively cure cervical spondylosis of vertebral artery type and does not have any adverse effect.
Description
technical field [0001] The invention relates to the field of pharmaceutical formulations, in particular to a compound anti-glare neck compound agent for treating vertebral artery type cervical spondylosis. Background technique [0002] Vertebral artery type cervical spondylosis is caused by insufficient blood supply to brain tissue and cerebral ischemia and hypoxia caused by cervical disc disease, cervical bone hyperplasia stimulation or compression of vertebral artery. It is mostly due to long-term incorrect use of the neck leading to cervical degenerative diseases, followed by degeneration of cervical intervertebral discs, changes in the physiological curvature of the cervical spine, and hyperostosis of the cervical spine, which stimulates and compresses the soft tissues of the neck and vertebral arteries, resulting in a complicated symptom. Syndrome. The onset age of vertebral artery type cervical spondylosis is higher than that of other types of cervical spondylosis, an...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.